ask="N/A"
ask_size="N/A"
average_daily_volume="56313"
bid="14.50"
bid_size="1000"
book_value="6.38"
change="-0.42"
change_from_200_day_moving_average="0.51"
change_from_50_day_moving_average="0.26"
change_from_52_week_high="-3.81"
change_From_52_week_low="3.87"
change_in_percent="-2.42%"
close="16.93"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.72"
ebitda="-48.18M"
eps_estimate_current_year="-4.11"
eps_estimate_next_quarter="-0.77"
eps_estimate_next_year="-3.46"
ex_dividend_date="N/A"
float_shares="6846000"
high="17.24"
high_52_weeks="20.74"
last_trade_date="2/14/2017"
last_trade_price="16.93"
last_trade_size="2013"
last_trade_time="4:00pm"
low="16.71"
low_52_weeks="13.06"
market_capitalization="367.80M"
moving_average_200_day="16.42"
moving_average_50_day="16.67"
name="Audentes Therapeutics
Inc."
notes="N/A"
one_year_target_price="22.33"
open="17.48"
pe_ratio="N/A"
peg_ratio="-1.53"
percent_change_from_200_day_moving_average="+3.09%"
percent_change_from_50_day_moving_average="+1.56%"
percent_change_from_52_week_high="-18.37%"
percent_change_from_52_week_low="+29.63%"
previous_close="17.35"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.72"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21725000"
short_ratio="14.63"
stock_exchange="NGM"
symbol="BOLD"
volume="24885"
weeks_range_52="13.06 - 20.74"
